Consistently, K-M survival analysis of the TCGA LIHC cohort revealed that HCC patients with lower CNOT4 expression had a poorer prognosis with lower OS rates compared with patients with higher CNOT4 expression (Fig. S6B). Here, CNOT4 is linked to hepatocellular carcinoma.